PINNACLE ASSOCIATES LTD – Regeneron Pharmaceuticals, Inc. Transaction History
PINNACLE ASSOCIATES LTD portfolio value:
$50.64M
portfolio value
PINNACLE ASSOCIATES LTD quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -17.11% | -15.17K shares | -1.78M | $688.87 | 73.51K |
Q2 2022 | share | Decrease | -3.29% | -3.01K shares | -11.62M | $591.13 | 88.68K |
Q1 2022 | share | Decrease | -3.97% | -3.79K shares | 3.73M | $698.42 | 91.70K |
Q4 2021 | share | Decrease | -1.47% | -1.42K shares | 1.65M | $642.51 | 95.49K |
Q3 2021 | share | Decrease | -2.48% | -2.46K shares | 3.14M | $605.18 | 96.91K |
Q2 2021 | share | Decrease | -1.10% | -1.11K shares | 7.96M | $558.54 | 99.38K |
Q1 2021 | share | Decrease | -5.05% | -5.34K shares | -3.58M | $473.14 | 100.49K |
Q4 2020 | share | Decrease | -4.41% | -4.88K shares | -10.84M | $483.11 | 105.83K |
Q3 2020 | share | Decrease | -1.91% | -2.15K shares | -8.41M | $559.78 | 110.72K |
Q2 2020 | share | Decrease | -5.82% | -6.97K shares | 11.87M | $623.65 | 112.87K |
Q1 2020 | share | Decrease | -15.48% | -21.94K shares | 5.28M | $488.29 | 119.84K |
Q1 2020 | call | Decrease | -100.00% | -900 shares | -338K | $488.29 | 0 |
Q4 2019 | call | Increase | 0.00% | 900 shares | 338K | $375.48 | 900 |
Q4 2019 | share | Decrease | -8.50% | -13.17K shares | 10.25M | $375.48 | 141.78K |
Q3 2019 | share | Decrease | -4.29% | -6.94K shares | -7.69M | $277.4 | 154.96K |
Q2 2019 | share | Decrease | -5.44% | -9.31K shares | -19.62M | $313 | 161.90K |
Q1 2019 | share | Decrease | -3.51% | -6.23K shares | 4.02M | $410.62 | 171.21K |
Q4 2018 | share | Decrease | -6.68% | -12.69K shares | -10.55M | $373.5 | 177.45K |
Q3 2018 | share | Decrease | -10.66% | -22.68K shares | 3.40M | $404.04 | 190.15K |
Q2 2018 | share | Decrease | -11.70% | -28.20K shares | -9.57M | $344.99 | 212.84K |
Q1 2018 | share | Decrease | -1.52% | -3.71K shares | -9.01M | $344.36 | 241.04K |
Q4 2017 | share | Decrease | -7.33% | -19.34K shares | -26.06M | $375.96 | 244.75K |
Q3 2017 | share | Decrease | -1.28% | -3.42K shares | -13.30M | $447.12 | 264.10K |
Q2 2017 | share | Decrease | -3.97% | -11.06K shares | 23.43M | $491.14 | 267.53K |
Q1 2017 | share | Decrease | -2.90% | -8.32K shares | 2.63M | $387.51 | 278.59K |
Q4 2016 | share | Decrease | -6.23% | -19.06K shares | -17.68M | $367.09 | 286.92K |
Q3 2016 | share | Decrease | -1.12% | -3.45K shares | 14.94M | $402.02 | 305.98K |
Q2 2016 | share | Increase | +0.20% | 620 shares | -3.24M | $349.23 | 309.43K |
Q1 2016 | share | Increase | +1.85% | 5.60K shares | -53.29M | $360.44 | 308.81K |